bioAffinity Technologies (BIAF) Shares Outstanding (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Shares Outstanding (Entity) of $4.5 million for Q1 2026, up 656.55% year-over-year from $594119.0 in Q1 2025, and up 161.16% quarter-over-quarter from $1.7 million in Q4 2025.
bioAffinity Technologies (BIAF) Shares Outstanding (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Shares Outstanding (Entity) for 6 consecutive years, with $4.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 656.55% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $4.5 million (up 656.55% YoY), while the FY2025 annual figure was $1.7 million, up 325.88% from the prior year.
- Shares Outstanding (Entity) rose to $4.5 million in Q1 2026 per BIAF's latest filing, from $1.7 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $4.5 million in Q1 2026 and bottomed at $89755.0 in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $709829.4 across 5 years, with a median of $373846.0 in 2024.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) grew 29.06% — and 2026, when it soared 656.55%.
- bioAffinity Technologies' Shares Outstanding (Entity) stood at $149950.0 in 2022, then surged by 108.82% to $313122.0 in 2023, then advanced by 29.06% to $404127.0 in 2024, then surged by 325.88% to $1.7 million in 2025, then soared by 161.16% to $4.5 million in 2026.
- Business Quant data shows BIAF's Shares Outstanding (Entity) at $4.5 million in Q1 2026, $1.7 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 371.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 705.30 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 78.95 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 282.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 166.10 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 141.50 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 151.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 20.12 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 111.00 Mn |
| 10 | bioAffinity Technologies | 2.38 Mn | -721,990.64 | - | 4.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.49 Mn |
| Dec 31, 2025 | 1.72 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 800,638.00 |
| Mar 31, 2025 | 541,861.00 |
| Dec 31, 2024 | 404,127.00 |
| Sep 30, 2024 | 413,021.00 |
| Jun 30, 2024 | 379,606.00 |
| Mar 31, 2024 | 330,481.00 |
| Dec 31, 2023 | 291,554.00 |
| Sep 30, 2023 | 289,856.00 |
| Jun 30, 2023 | 283,995.00 |
| Mar 31, 2023 | 281,095.00 |
| Dec 31, 2022 | 149,950.00 |
| Sep 30, 2022 | 140,112.00 |
| Jun 30, 2022 | 89,775.00 |
| Mar 31, 2022 | 89,365.00 |
| Dec 31, 2021 | 89,167.00 |
| Sep 30, 2021 | 89,160.00 |